For The 1st time, WHO’s treatment rules include a transparent advice for the use of extensive-acting injectable cabotegravir and rilpivirine (Taxi/RPV) as a substitute switching selection for antiretroviral therapy (Artwork) for adults and adolescents who've reached full viral suppression on oral Artwork and don't have active hepatitis B infection. Experts https://g.page/r/CfXqQhfboBkBEBM